Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification
B Meeusen, V Janssens - The international journal of biochemistry & cell …, 2018 - Elsevier
Aberrant protein phosphorylation is one of the hallmarks of cancer cells, and in many cases
a prerequisite to sustain tumor development and progression. Like protein kinases, protein …
a prerequisite to sustain tumor development and progression. Like protein kinases, protein …
Updates in glioblastoma immunotherapy: an overview of the current clinical and translational scenario
Glioblastoma (GBM) is the most common and aggressive central nervous system tumor,
requiring multimodal management. Due to its malignant behavior and infiltrative growth …
requiring multimodal management. Due to its malignant behavior and infiltrative growth …
[HTML][HTML] miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas
J Liu, J Xu, H Li, C Sun, L Yu, Y Li, C Shi, X Zhou… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Down-regulation of miR-146b-5p contributes to tumorigenesis in several human cancers.
However, the relevance of miR-146b-5p to prognosis, proliferation and apoptosis in gliomas …
However, the relevance of miR-146b-5p to prognosis, proliferation and apoptosis in gliomas …
The role of cytoreductive surgery in the management of progressive glioblastoma: a systematic review and evidence-based clinical practice guideline
Question Should patients with previously diagnosed malignant glioma who are suspected of
experiencing progression of the neoplasm process undergo repeat open surgical resection …
experiencing progression of the neoplasm process undergo repeat open surgical resection …
Genomic, epigenomic and transcriptomic landscape of glioblastoma
The mostly aggressive and extremely malignant type of central nervous system is
Glioblastoma (GBM), which is characterized by an extremely short average survival time of …
Glioblastoma (GBM), which is characterized by an extremely short average survival time of …
The tumor suppressor PTPRK promotes ZNRF3 internalization and is required for Wnt inhibition in the Spemann organizer
LS Chang, M Kim, A Glinka, C Reinhard, C Niehrs - Elife, 2020 - elifesciences.org
A hallmark of Spemann organizer function is its expression of Wnt antagonists that regulate
axial embryonic patterning. Here we identify the tumor suppressor Protein tyrosine …
axial embryonic patterning. Here we identify the tumor suppressor Protein tyrosine …
[HTML][HTML] Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies
The vast majority of malignant gliomas relapse after surgery and standard radio-
chemotherapy. Novel molecular and cellular therapies are thus being developed, targeting …
chemotherapy. Novel molecular and cellular therapies are thus being developed, targeting …
[HTML][HTML] Silencing of lncRNA CCDC26 restrains the growth and migration of glioma cells in vitro and in vivo via targeting miR-203
S Wang, Y Hui, X Li, Q Jia - Oncology Research, 2018 - ncbi.nlm.nih.gov
Gliomas are the most common primary brain tumors with high mortality. The treatment for
gliomas is largely limited due to its uncomprehending pathological mechanism. Here we …
gliomas is largely limited due to its uncomprehending pathological mechanism. Here we …
Glioblastoma genomics: a very complicated story
MY Lombardi, M Assem - Exon Publications, 2017 - exonpublications.com
Glioblastoma is a deadly disease that has not shown improvement despite the development
of new diagnostic tools and innovative targeted therapies. This grim outcome is mainly …
of new diagnostic tools and innovative targeted therapies. This grim outcome is mainly …
The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity
PH Chen, WL Shen, CM Shih, KH Ho, CH Cheng… - …, 2017 - Elsevier
Glioblastoma multiforme (GBM) is the high-grade primary glioma in adults. Temozolomide
(TMZ), an alkylating agent of the imidazotetrazine series, is a first-line chemotherapeutic …
(TMZ), an alkylating agent of the imidazotetrazine series, is a first-line chemotherapeutic …